Loading clinical trials...
Loading clinical trials...
Clinical Protocol for the Prospective Evaluation of a Commercially Available Hydrogel Spacer
Dosimetry efficacy evaluation of the hydrogel spacer
Single arm study for evaluation of dosimetry following use of a commercially available hydrogel spacer implanted in 20 males undergoing radiotherapy to treat prostate cancer. Study will utilize pre and post gel insertion CT images to determine the endpoints.
Age
18 - No limit years
Sex
MALE
Healthy Volunteers
No
Western Radiation Oncology
Campbell, California, United States
Northern Nevada Radiation Oncology
Reno, Nevada, United States
Start Date
November 20, 2020
Primary Completion Date
June 29, 2021
Completion Date
February 8, 2022
Last Updated
September 16, 2025
20
ACTUAL participants
Observation
OTHER
Lead Sponsor
BioProtect
NCT06842498
NCT04550494
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05691465